DGX
Quest Diagnostics Incorporated
NYSE: DGX · HEALTHCARE · DIAGNOSTICS & RESEARCH
$189.32
-2.94% today
Updated 2026-04-29
Market cap
$20.96B
P/E ratio
20.92
P/S ratio
1.86x
EPS (TTM)
$9.05
Dividend yield
1.67%
52W range
$162 – $213
Volume
0.9M
Quest Diagnostics Incorporated (DGX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+3.5%
Last 4 quarters
Revenue YoY growth
+9.2%
Most recent quarter
EPS YoY growth
+13.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+0.3%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+9.4%
2026-02-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-28 | $2.50 | +5.5% | $196.63 | $189.32 | -3.7% |
| 2026-02-10 | $2.42 | +2.5% | $191.25 | $209.32 | +9.4% |
| 2025-10-21 | $2.60 | +4.0% | $190.41 | $181.17 | -4.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $2.37 | $2.50 | +5.5% | $2.90B | +9.2% |
| 2025-12-31 | $2.36 | $2.42 | +2.5% | $2.81B | +7.1% |
| 2025-09-30 | $2.50 | $2.60 | +4.0% | $2.82B | +13.2% |
| 2025-06-30 | $2.57 | $2.62 | +1.9% | $2.76B | +15.2% |
| 2025-03-31 | $2.15 | $2.21 | +2.8% | $2.65B | +12.1% |
| 2024-12-31 | $2.18 | $2.23 | +2.3% | $2.62B | +14.6% |
| 2024-09-30 | $2.26 | $2.30 | +1.8% | $2.49B | +8.4% |
| 2024-06-30 | $2.34 | $2.35 | +0.4% | $2.40B | — |
| 2024-03-31 | $1.86 | $2.04 | +9.7% | $2.37B | — |
| 2023-12-31 | $2.11 | $2.15 | +1.9% | $2.29B | — |
| 2023-09-30 | $2.19 | $2.22 | +1.4% | $2.29B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $10.74 | $11.9B | +7.5% | 13 | high |
| 2027 (E) | $11.55 | $12.3B | +3.7% | 13 | medium |
| 2028 (E) | $12.15 | $12.8B | +4.4% | 13 | medium |
| 2029 (E) | $12.75 | $13.4B | +4.4% | 13 | medium |
| 2030 (E) | $13.40 | $14.0B | +4.5% | 13 | low |
Frequently asked questions
Has Quest Diagnostics Incorporated beaten earnings estimates?
Quest Diagnostics Incorporated has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +3.5% over the last 4 quarters.
How does DGX stock react to earnings?
DGX stock has moved an average of +0.3% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Quest Diagnostics Incorporated's revenue growth rate?
Quest Diagnostics Incorporated reported year-over-year revenue growth of +9.2% in its most recent quarter, with EPS growing +13.1% year-over-year.
What is the expected EPS for DGX in 2026?
Analysts expect Quest Diagnostics Incorporated to report EPS of $10.74 for fiscal year 2026, on revenue of $11.9B, based on estimates from 13 analysts.